TPM2 mutations are associated with various congenital myopathies, including nemaline myopathy, cap myopathy, and distal arthrogryposis, with underlying mechanisms involving calcium sensitivity abnormalities and sarcomere structural disruption [62–65]. Here, TPM2 is linked to cap myopathy.